Cargando…
Epigenetic Biomarkers for Parkinson’s Disease: From Diagnostics to Therapeutics
Parkinson’s disease (PD) is a prevalent neurodegenerative illness that is often diagnosed after significant pathology and neuronal cell loss has occurred. Biomarkers of PD are greatly needed for early diagnosis, as well as for the prediction of disease progression and treatment outcome. In this rega...
Autores principales: | Jakubowski, Jennifer L., Labrie, Viviane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302044/ https://www.ncbi.nlm.nih.gov/pubmed/27792016 http://dx.doi.org/10.3233/JPD-160914 |
Ejemplares similares
-
The Appendix in Parkinson’s Disease: From Vestigial Remnant to Vital Organ?
por: Killinger, Bryan, et al.
Publicado: (2019) -
Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson’s Disease?
por: Thirtamara-Rajamani, Keerthi, et al.
Publicado: (2017) -
Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms
por: Li, Peipei, et al.
Publicado: (2019) -
Hemispheric asymmetry in the human brain and in Parkinson’s disease is linked to divergent epigenetic patterns in neurons
por: Li, Peipei, et al.
Publicado: (2020) -
Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease
por: Gordevicius, Juozas, et al.
Publicado: (2021)